Pharma scores poorly in ‘environment’ in ESG ratings Korea Biomedical ReviewPharma scores poorly in ‘environment’ in ESG ratings Korea Biomedical ReviewPharma scores poorly in ‘environment’ in ESG ratings Korea Biomedical Review
Impact Investing Forum 2024
https://impactinvestingconferences.com/
London. April 24-25, 2023.